Encompass Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Encompass Wealth Advisors's PFE Position: Q4 2025 in Review
Encompass Wealth Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 15,276 shares — an estimated $389K sold.
Encompass Wealth Advisors first reported a position in PFE in Q4 2020 and held it in 20 quarters. The position peaked at $685K in Q4 2021. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Encompass Wealth Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Encompass Wealth Advisors sold 15,276 Pfizer shares in Q4 2025, an estimated $389K.
- Encompass Wealth Advisors first reported a position in Pfizer in Q4 2020 and held it in 20 quarters.
- Encompass Wealth Advisors's Pfizer position peaked at $685K in Q4 2021.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Encompass Wealth Advisors's 13F filing for Q4 2025, filed 22 Jan 2026.